Avon Lifesciences Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,032
291
325
-
-
61,454
Cost of Goods Sold (COGS) incl. D&A
1,152
438
340
-
-
61,454
Gross Income
120
147
14
-
-
61,454
SG&A Expense
32
30
20
39
30
29,941
EBIT
152
177
34
107
95
91,395
Unusual Expense
-
25
-
-
-
-
Non Operating Income/Expense
-
48
5
9
59
8,761
Interest Expense
240
156
144
144
145
144,439
Pretax Income
343
303
165
192
239
244,595
Consolidated Net Income
348
303
165
165
239
244,595
Net Income
348
303
165
165
239
244,595
Net Income After Extraordinaries
348
303
165
165
239
244,595
Net Income Available to Common
348
303
165
165
239
244,595
EPS (Basic)
15.47
13.45
6.94
6.94
10.04
10.27
Basic Shares Outstanding
23
23
24
24
-
-
EPS (Diluted)
15.47
13.45
6.94
6.94
-
-
Diluted Shares Outstanding
23
23
24
24
-
-
EBITDA
56
99
39
39
30
29,941
Non-Operating Interest Income
-
1
1
4
-
-
Other After Tax Income (Expense)
-
-
-
28
-
-
About Avon Lifesciences
View Profile
